awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q44006206-174F5B96-D77E-4F6B-A88E-A3A6A43C5260
Q44006206-174F5B96-D77E-4F6B-A88E-A3A6A43C5260
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44006206-174F5B96-D77E-4F6B-A88E-A3A6A43C5260
An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease.
P2860
Q44006206-174F5B96-D77E-4F6B-A88E-A3A6A43C5260
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44006206-174F5B96-D77E-4F6B-A88E-A3A6A43C5260
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
83779ad1f4d7a597c1a1c2ce8e30ad92876c39df
P2860
Thalomid (Thalidomide) capsules: a review of the first 18 months of spontaneous postmarketing adverse event surveillance, including off-label prescribing.